Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver

Sherief Abd-Elsalam100 enrolled

Overview

The study aimed to investigate the preemptive analgesia efficacy of of preemptive pregabalin for the postoperative pain management after radiofrequency ablation (RFA) of liver cancer.

Our data will investigate if preemptive administration of pregabalin will have a role in reducing postoperative pain after radiofrequency ablation (RFA) of liver cancer.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

100

Conditions

Hepatocellular Cancer

Interventions

Pregabalin 150mgDRUG

Pregabalin 150mg before RFA of liver cancer

PlaceboOTHER

Placebo before RFA of liver cancer

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * HCC patients, Child A, B, scheduled for Radiofrequency ablation of HCC. Exclusion Criteria: * Encephalopathy, Renal impairment

Locations (1)

Tanta university - faculty of medicine

Cairo, Elgharbia, Egypt

RECRUITING

Outcomes

Primary Outcomes

visual analogue pain scale (VAS Pain) post operatively

Amplitude of pain postoperatively

Time frame: 2 weeks

Central Contacts

Sherief Abd-Elsalam, consultant

CONTACT

00201095159522 Sheriefabdelsalam@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.